Pficeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`Complete if Known
`
`Application Number —
`
`
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) _—
`_—
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH“
`
`DuKJW
`
`U.S. PATENTS
`
`Cite
`No.
`
`Document Number
`_
`.
`2
`.
`Number Kmd Code (If
`
`Name of Patentee or
`Issue or
`Publication Date Applicant ofCited Document
`YYYY-MM-DD
`
`Pages, Columns,
`Lines, Where
`Relevant Passages or
`Relevant
`
`Figures Appear
`-_———
`-_———
`-_———
`-I_-__VASILIEVICH et al.
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-- 8030348
`2011-10-04
`Sampalis, Fotni —
`
`known)
`
`8383675
`
`8586567
`
`2013-02-26
`
`Sampalis
`
`2013-11-19
`
`SAMPALIS, F.
`
`8697138
`
`2014-04-15
`
`Bruheim et al.
`
`Date
`Examiner
`GE/02/2913
`Considered
`,IDEBORAH K WARE/
`Signature
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/D.K.W/
`
`

`

`Pficeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`Complete if Known
`
`Application Number —
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`
`known)
`
`U.S. PUBLISHED PATENT APPLICATIONS
`
`Citeé
`No.
`
`Document Number
`_
`.
`4
`.
`Number Kmd Code (If
`
`Name of Patentee or
`Issue or
`Publication Date Applicant ofCited Document
`YYYY-MM-DD
`
`Pages, Columns,
`Lines, Where
`Relevant Passages or
`Relevant
`
`Figures Appear
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`-_———
`20110256216
`2011-10-20
`LEFKOWITZ ANDREW R.
`
`20140274968
`
`2014-09-18
`
`BERGE KJETIL et al.
`
`20140370115
`
`2014-12-18
`
`HOEM, Nils et al.
`
`Note: Submission of copies of U.S. Patents and published U.S. Patent Applications is not required.
`
`FOREIG-N PATENT DOCUMENTS
`
`Examiner
`
`Date
`
`[DEBORAH K WARE/
`
`09/02/2018
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`ALL REFERENCES CONSIDERED EXCEPT WERE LINED THROUGH.
`,I’D .K.W/
`
`

`

`
`
`1987-03-12
`
`Neptune Technologies &
`Bioressources, Inc.
`SATO
`
`1981-04-07
`
`Inst.
`
`1981-04-07
`
`2000-04-21
`
`1997-07-08
`
`2014-01-15
`
`Elementoorganicheskikh
`So, et al.
`
`ROGOZHIN, et aI
`
`Beaudoin
`
`Tepual S.A.
`UNIV. SHANDONG
`NORMAL
`
`1994-08-03
`
`SCOTIA HOLDINGS PLC
`
`1995-06-09
`
`NIPPON OIL CO. LTD
`
`2005-09-07
`
`|.B.R ISRAELI
`
`BIOTECHNOLOGY
`
`RES EARCH LTD.
`
`Pficeipt date: {36/29/2018
`
`16/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`Application Number —
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`
`FOREIG-N PATENT DOCUMENTS
`
`2 1°
`
`Foreign Patent Document
`
`Publication Date
`YYYY-MM-DD
`
`Name of Patentee or
`Applicant of Cited
`Document
`
`Country Code5 Number6
`Kind Code7 (if known)
`
`Translati
`on8
`
`Pages,
`Columns,
`Lines, Where
`Relevant
`Passages or
`Relevant
`
`Figures
`Appear
`
`AU 2002322233
`
`2003-02-17
`
`BR 8701265
`
`CA 1098900
`
`CA 1098900
`
`CA 2251265
`
`CL 40348
`
`CN 102746941
`
`EP 0609078
`
`EP 0670306
`
`EP 0973532
`
`EP 1123368
`
`2008-04-09
`
`UNIVERSITE DE
`
`SHERBROOKE
`
`EP 1127497
`
`2001-08-29
`
`NIPPON SUISAN KAISHA
`
`LTD
`
`EP 1292294
`
`EP 1385500
`
`2009-03-18
`
`ACCERA, INC.
`
`2010-07-28
`
`YEDA RESEARCH AND
`
`EP 1392623
`
`2004-03-03
`
`DEVELOPMENT CO. LTD
`
`MARTEK BIOSCIENCES
`BOULDER CORPORATION
`
`EP 1406641
`
`2004-04-14
`
`NEPTUNE TECHNOLOGIES
`
`& BIORESSOURCES INC.
`
`EP 1419768
`
`2009-01-07
`
`NEPTUNE TECHNOLOGIES
`
`& BIORESOURCES, INC
`
`Date
`Examiner
`09 92 2018
`Cmfimmd
`EEBQRAH K WARE.
`smmmm
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WERE LINED THROUGH.
`
`fD.K.W/
`
`

`

`Pficeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`Application Number —
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`
`FOREIG-N PATENT DOCUMENTS
`
`-- EP 1542670
`EP 1631280
`
`2005-06-22
`2004-04-08
`
`SUNTORY LIMITED _-
`BTG INTERNATIONAL
`
`LIMITED
`
`-- EP 1660071
`-- EP 1689413
`
`2007-01-17
`2006-08-16
`
`LTD.
`
`NIPPON SUISAN KAISHA, --
`ENZYMOTEC LTD _-
`
`
`
`NIPPON SUISAN KAISHA, --
`2007-01-17
`-- EP 1743531
`-_———-
`-_———-
`-_———-
`-_———-
`JP 2003-530448
`2003-10-14
`Westfalia Separator
`
`LTD.
`
`Industry GmbH
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`JP 4012665
`1992-01-17
`MATSUSHITA ELECTRIC IND
`
`JP 60-153779
`
`1985-08-13
`
`JP 61281159
`
`1986-12-11
`
`CO LTD
`
`Honen Seiyu CO. Ltd. Et al.
`
`SHISEIDO CO LTD; NIPPON
`SUISAN KAISHA LTD.
`
`JP HOS-231391
`
`Examiner
`
`Kanagawa Kagaku
`
`Kenkyuujo CO., Ltd. Et al.
`
`Date
`
`09/02/2018
`”WORM K WARE/
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WERE LINED THROUGHL fD..K.W/
`
`

`

`Pficeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`Application Number —
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`
`-- JP S6323819
`JP-A-2001-158736
`
`1988-02-01
`2001-06-12
`
`HARAK K. et aI. _-
`SNOW BRAND MILK PROD
`
`FOREIG-N PATENT DOCUMENTS
`
`-- JP-A-2003-003192
`-- JP-A-2003—048831
`JP-A-2003—146883
`
`-- JP-A-2005-245379
`-- JP-A-2006-069948
`JP-A-2006-083136
`
`2003-01-08
`2003-02-21
`2003-05-21
`
`2005-09-15
`2006-03-16
`2006-03-30
`
`CO LTD
`
`UNITIKA LTD _-
`SUNTORY LTD _-
`SNOW BRAND MILK PROD
`co LTD
`
`LTD
`
`NIPPON SUISAN KAISHA --
`HIROSE YUKIHIRO _-
`SUNTORY LTD
`
`JP-A-2006-290784
`
`2006-10-26
`
`HIROSE YUKIHIRO
`
`JP-A-2006-316073
`
`2006-11-24
`
`IBR ISRAELI
`
`BIOTECHNOLOGY
`
`RES EARCH LTD
`
`JP-A-2006-328014
`
`2006-12-07
`
`HIROSE YUKIHIRO
`
`JP-A-2007-126455
`
`2007-05-24
`
`FUJI CHEM IND CO LTD
`
`JP-A-2007-246404
`
`2007-09-27
`
`SNOW BRAND MILK PROD
`
`JP-A-S51-125774
`
`JP-A-S52-114046
`
`1976-11-02
`
`1977-09-24
`
`CO LTD
`
`Nichiro Gyogyo et aI.
`Kokai
`
`SU 220741
`
`1971-01-06
`
`KRGUCHKOV
`
`WO 01/76385
`
`2001-10-18
`
`WO 02/102394
`
`2002-12-27
`
`Westfalia Separator
`Industry GmbH
`
`Neptune Technologies &
`Bioress
`
`Norway Seafoods AS
`SC DICOPHAR
`
`Aker Biomarine ASA
`
`Catchpole
`
`Nippon Suisan Kaisha, Ltd.
`Aker Biomarine ASA
`
`
`
`WO 05/004593
`
`WO 06/111633
`
`WO 07/080515
`
`WO 07/123424
`
`WO 08/072563
`
`wo 08/117062
`
`WO 1986/06082
`
`2005-01-20
`
`2006-10-26
`
`2007-07-19
`
`2007-11-01
`
`2008-06-19
`
`2008-10-02
`
`1986-10-23
`
`MAT-CON RADGIVENDE
`
`INGENI¢RFIRMA A/S
`
`WO 1990/05765
`
`1990—05-31
`
`MIKALSEN
`
`Examiner
`99/02/2913
`/DEBORAH K W/
`Signature
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`Date
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH“
`
`/D.K.,W/
`
`

`

`Pficeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`Application Number —
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) _—
`_—
`___——“
`
`FOREIG-N PATENT DOCUMENTS
`
`-- wo 1993/24142
`WO 1997/38585
`
`1993-12-09
`1997-10-23
`
`PHAIRSON MEDICAL AB _-
`THE UNIVERSITY OF
`BRITISH COLUMBIA
`
`WO 1997/39759
`
`1997-10-30
`
`BRIGHAM AND WOMEN’S
`HOSPITAL
`
`-- wo 1998/34498
`
`1998-08-13
`
`BIOZYME SYSTEMS INC. _-
`
`-- wo 2000/23546
`-- wo 2000/25608
`-- wo 2000/38708
`WO 2001/028526
`
`2000-04-27
`2000-05-11
`2000-07-06
`2001-04-26
`
`LTD.
`
`UNIV SH ERBROOKE _-
`NIPPON SUISAN KAISHA, _-
`PHAIRSON MEDICAL INC. _-
`TRUFFINI & REGGE
`FARMACEUTICI
`
`DEVELOPMENT CO. LTD
`
`BOULDER CORPORATION
`
`-_———-
`-I_-_--
`-I_-_--
`-I-_--& BIORESS
`-I_-_--
`-I_-_--
`-_———-
`-- wo 2004/028529
`2004-04-08
`SUNTORY LIMITED _-
`-- wo 2004/047554
`2004-06-10
`PHARES PHARM RES NV _-
`WO 2004/112767
`2004-12—29
`Advanced Bionutrition
`
`
`
`DEVELOPMENT CO. LTD
`
`& BIORESSOURCES INC.
`
`WO 2004-100943
`
`2006-05-31
`
`Corp.
`BTG INTERNATIONAL
`
`LIMITED
`
`-_———-
`
`-_——
`-_——
`
`Examiner
`
`Date
`
`99/02/2918
`CmEflmd
`/DEBORAH K WARE/
`Sbmmm
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/D.K.W/
`
`

`

`Raczeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`Application Number —
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`
`FOREIG-N PATENT DOCUMENTS
`
`AS
`
`--————-
`-_———-
`-_———-
`-_———-
`-- wo 2007/108702
`2007-09-27
`AKER SEAFOODS HOLDING --
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`-_———-
`WO 97/38585
`1997-10-23
`The University of British
`Columbia
`
`- wo 98/34498
`- wo 99/39589
`
`1998-08-13
`1999-08-12
`
`Biozyme Systems, Inc. _-
`Biozyme Systems Inc. _-
`
`NONPATENT LITERATURE DOCUMENTS
`
`Include name of the author (in CAPITAL LETTERS), title ofthe article (when
`appropriate), title of the item (book, magazine, journal, serial, symposium, catalog,
`etc.), date, page(s), volume-issue number(s), publisher, city and-or country where
`published.
`
`Translatio
`
`
`
`ALI-NEHARI et a|., "Characterization of purified phospholipids from krill () residues
`deoiled by supercritical carbon dioxide", Korean Journal of Chemical Engineering,
`2012, vol. 29, no. 7
`
`ALLAHPICHAY et a|., "Extraction of Growth Promoting Fractions from Non-muscle Krill
`Meal of Euphausia superba and its Effect on Fish Growth," Bulletin of the Japanese
`
`Society of Scientific Fisheries, 1984, 50(5): 821-826
`
`Date
`Examiner
`09/02/2018
`Cm§mmd
`/DEBQRAH K WABE/
`Sbmmm
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`I’D .K.W/
`
`

`

`Pficeipt date: 06/29/2018
`
`16,/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`——
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`___——-
`
`NONPATENT LITERATURE DOCUMENTS
`
`ANDO and HATANO, 1988, ”Isolation of apolipoproteins from carotenoid-carrying
`
`lipoprotein in the serum of chum salmon, Oncorhynchus keta”, J. Lipid Research, 29:
`1264-1271
`
`AOI et al., 2003, ”Astaxanthin limits exercise-induced skeletal and cardiac muscle
`
`damage in mice”, Antioxidants & Redox Signaling, 5(1): 139-44
`-- April 2, 2012 Response to Office Action, ’351 patent
`
`.BALASSA et al., Microencapsulation in the Food Industry, Critical Reviews in Food.Technology, 2:2, 245-265 (1971)(”Balassa”)
`
`-
`
`BELL and Dick, Molecular Species Composition of the Major Diacyl
`
`Glycerophospholipids from Muscle, Liver, Retina and Brain of Cod (Gadus morhua),
`
`Lipids, Vol. 26, No. 8, pp. 565-573 (1991) (”Bell and Dick”)
`
`BELL, Molecular Species Analysis of Phosphoglycerides from the Ripe Roes of Cod,
`
`Lipids, Vol. 24, No. 7 (1989)
`
`BELL, Molecular Species Composition of Phosphatidylcholine from Crypthecodinium
`
`cohnii in Relation to Growth Temperature Lipids 25, 115-118 (1990)
`
`
`
`- BERGELSON (ed.), Lipid Biochemical Preparations, Chapter |.1, pp. 1-13 (1980) -
`
`(”Bergelson”)
`
`BOTI'INO N.R., ”Lipid Composition of Two Species of Antarctic Krill: Euphausia
`Superba and E. Crystallorophias,” Comp. Biochem. Physiol., 1975, Vol. 50B, pp.
`479-484
`
`BRITTON, 1985, ”General Carotenoid Methods”, Methods in Enzymology, Vol 111, pp.
`113-149
`
`BRZUSTOWICZ, Michael R., et al., "Controlling Membrane Cholesterol Content. A
`
`Role for Polyunsaturated (Docosahexaenoate) Phospholipids," Biochemistry (2002),
`41, pp. 12509-12519
`-- Buchi R-220 Rotovapor® Manual, dated November 16, 2009, pages 1-50 -
`BUDA, Structural order of membranes and composition of phospholipids in fish brain
`
`cells during thermal acclimatization, Proc. Natl. Acad. Sci. USA Vol. 91, pp. 8234-8238,
`August 1994
`
`BUDZINSKLI, E., et al., "Possibilities of processing and marketing of products made
`
`from Antarctic Krill", FAO Fish. Tech. Pap. (268) 46 pages (1985) (BUDZINSKI)
`
`BUNEA R., et al.., "Evaluation of the Effects of Neptune Krill Oil on the Clinical Course
`of Hyperlipidemia," Alternative Medicine Review, Thorne Research Inc., Sandpoint,
`
`US, Vol. 9, No. 4, January 1, 2004
`
`CALDER, 2006, ”n-3 polyunsaturated fatty acids, inflammation, and inflammatory
`diseases”, Am. J. Clin. Nutr., 83: 1505S
`
`Examiner
`
`Date
`
`09/02/2018
`,I’DEBORAH K WARE/
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WERE LINED THROUGH.
`
`/D.K.W/
`
`

`

`Pficeipt date: 06/29/2018
`
`16,/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`——
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`—————-
`
`
`
`NONPATENT LITERATURE DOCUMENTS
`
`Certificate of translation of Ex. 1072: Fisheries Agency, General Report on Research
`
`and Development of Techniques in Processing and Utilization of Marine Products,
`
`Chapter 6, Development of technology for recovery of valuable substances
`(astaxanthin) from krill, by Takao Fujita, pp. 273-307 (March 1985); Japanese
`language document
`
`Certificate of translation of Ex. 1074: Japanese Patent No. 60-153779, entitled
`”Nutritional Supplement”
`
`Certificate of translation of Ex. 1076: Japanese Patent Publication No. H08-231391,
`
`entitled ”Medicine for Improvement of Dementia Symptoms”
`
`Certification of translation of Ex. 1070: Japanese Unexamined Patent Application
`Publication No. 02-215351
`
`Certified translation of Ex. 1070: Japanese Unexamined Patent Application
`
`Publication No. 02-215351, titled Krill Phospholipids Fractioning Method
`
`(”Maruyama,”); Certificate of Translation provided as Ex. 1071; dated July 9, 2013, 1
`page
`
`Certified translation of Ex. 1072: Fisheries Agency, General Report on Research and
`
`Development of Techniques in Processing and Utilization of Marine Products,
`
`Chapter 6, Development of technology for recovery of valuable substances
`(astaxanthin) from krill, by Takao Fujita, pp. 273-307 (March 1985) (”Fujita”);
`Certificate of Translation provided as Ex. 1073.
`
`Certified translation of Ex. 1074: Japanese Patent No. 60-153779, entitled
`
`”Nutritional Supplement” (”Fukuoka ”); Certificate of Translation provided as Ex.
`1075, dated August 16, 2013
`
`Certified translation of Ex. 1076: Japanese Patent Publication No. H08-231391,
`
`entitled ”Medicine for Improvement of Dementia Symptoms” (”Yasawa”); Certificate
`of Translation provided as Ex. 1077, dated August 16, 2013, 1 page
`
`CHAREST et al., 2001, ”Astaxanthin Extraction from Crawfish Shells by Supercritical
`
`C02 with Ethanol as Cosolvent”, J. Aquatic Food Product Technology, 10(3): 79-93
`
`CHEN and MEYERS, 1982, ”Extraction of Astaxanthin Pigment from Crawfish Waste
`
`Using a Soy Oil Process”, J. Food Sci., 47: 892-896
`
`CLARKE, 1980, ”The Biochemical Composition of Krill, Euphausia superba dana,from
`
`South Georgia”, J. Exp. Mar. Biol. Ecol., 43: 221-236
`
`CN Office Action mailed April 27, 2012, JP Patent Application No. 200880112125.6
`(and English translation)
`-- CRC 2013-2014, 94th ed., pp. 6-231-6-235
`CZECZUGA, 1974, ”Comparative Studies of Carotenoids in the Fauna of the Gullmar
`Fjord (Bohuslan, Sweden). ||. Crustacea: Eupagurus bernhardus, Hyas coarctatus and
`Upogebia deltaura”, Marine Biology, 28: 95-98
`
`-
`
`Examiner
`
`Date
`
`09/02/2018
`WWWRE/
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WERE LINED THROUGH.
`
`fD.K.W/’
`
`

`

`Pficeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`——
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`
`NONPATENT LITERATURE DOCUMENTS
`
`Database FSTA [Online} International Food Information Service, Frankfurt-Main;
`
`SHIBATA N. "Effect of fishing season on lipid content and composition of Antarctic
`
`krill (translated)" Database accession no. FS-1985-04-r-0091, abstract only
`-- DATABASE WPI Week 200682, Thomson Scientific, London, GB, 2006 -
`DE RI'I'I'ER and PURCELL, 1981, ”Carotenoid Analytical Methods”, Carotenoids as
`
`
`
`Colorants and Vitamin A Precursors: Technological and Nutritional Applications, pp
`815-882
`
`December 8, 2011 Office Action, KR Patent Application No. 10-2010-7006897 and its
`
`English translation
`
`Declaration of Bjorn Ole Haugsgjerd in support of Inter Partes Review of U.S. Pat. No.
`
`8,278,351 (”Haugsgjerd”), dated September 30, 2013, 12 pages
`
`Declaration of Bjorn Ole Haugsgjerd submitted during inter partes reexamination of
`
`parent patent U.S. 8,030,348 (”Haugsgjerd ’348 Decl.”)
`
`Declaration of Dr. Albert Lee in Support of Inter Partes Review of U.S. Pat. No.
`
`8,278,351 (”Lee”)
`
`Declaration of Dr. Albert Lee in Support of Inter Partes Review of U.S. Pat. No.
`
`8,383,675 (”Lee”)
`
`Declaration of Dr. Chong Lee submitted during inter partes reexamination of parent
`patent U.S. 8,030,348 (”Yeboah Reexam Decl.”)
`
`Declaration of Dr. Earl White submitted during prosecution of parent patent U.S.
`8,030,348 (”2011 White Decl.”)
`
`Declaration of Dr. Ivar Storr¢ in support of Inter Partes Review of U.S. Pat. No.
`
`8,278,351 (”Storr¢”)
`
`Declaration of Dr. Ivar Storr¢ in support of Inter Partes Review of U.S. Pat. No.
`
`8,383,675 (”Storr¢”)
`
`Declaration of Dr. Jacek Jaczynski from inter partes reexamination of the parent
`
`patent U.S. 8,030,348 (”Jaczynski Reexam. Decl.”)
`
`Declaration of Dr. Jaczynski submitted during prosecution of parent patent U.S.
`
`8,278,351 (Jaczynski ’351 Decl.”)
`
`Declaration of Dr. Jeff Moore in Support of Inter Partes Review of U.S. Pat. No.
`
`8,278,351 (”Moore”)
`
`Declaration of Dr. Jeff Moore in Support of Inter Partes Review of U.S. Pat. No.
`8,383,675 (”Moore”)
`
`Declaration of Dr. Richard van Breemen in Support of Inter Partes Review of U.S. Pat.
`No.8,278,351(”Van Breemen”)
`
`Declaration of Dr. Richard van Breemen in Support of Inter Partes Review of U.S. Pat.
`
`No. 8,383,675 (”Van Breemen”)
`
`Examiner
`
`Date
`
`00/02/0000
`000000000000
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/D.K.W/
`
`

`

`Pficeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`Application Number —
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`
`NONPATENT LITERATURE DOCUMENTS
`
`Declaration of Dr. Shahidi submitted during inter partes reexamination of parent
`
`8,278,351 (Shahidi ’351 DecI.”)
`
`8,278,351 (”Budge”)
`
`
`
`-
`-- patent U.S. 8,030,348 (Shahidi Reexam. DecI.”)
`-- Declaration of Dr. Shahidi submitted during prosecution of parent patent U.S. -
`-- Declaration of Dr. Suzanne Budge in Support of Inter Partes Review of U.S. Pat. No. -
`.Ii,
`-
`-_-
`-_-
`-- parent patent U.S. 8,030,348 (”Gundersen DecI.”)
`-
`-- parent patent U.S. 8,030,348 (SampaIis”)
`-
`-- patent (Van Breemen ’351 Reexam. DecI.”
`-
`-- Declaration of Dr. Van Breemen submitted during Inter partes Reexamination of the -
`-- patent U.S. 8,030,348 (”Yeboah Reexam DecI.”)
`-
`-- 8,278,351 (”Yeboah ’351 DecI.”)
`-
`-- polyunsaturated fatty acid intake”, Eur. J. Clin. Nutr., 49(7): 508-16 -
`-- human disease”, Eur. J. Endocrinol., 148(3): 293-300
`-
`-- Soap 51-54, 1939 (”Eichberg”)
`-
`-- mortem. Autoproteonsis." Biochem. J. 246, 295-305
`-
`-- EMODI, 1978, ”Carotenoids: Properties and Applications”, Food Technology, 32(5): 38-
`EP Opposition filed February 13, 2014 by Olympic Seafood AS, EP Patent Application
`No. EP08718910|6
`
`Declaration of Dr. Suzanne Budge in Support of Inter Partes Review of U.S. Pat. No.
`
`Declaration of Dr. Thomas Brenna in support of Inter Partes Review of U.S. Pat. No.
`
`Declaration of Dr. Thomas Brenna in support of Inter Partes Review of U.S. Pat. No.
`
`Declaration of Dr. Thomas Gundersen submitted during inter partes reexamination of
`
`Declaration of Dr. Tina SampaIis submitted during inter partes reexamination of
`
`Declaration of Dr. Van Breemen submitted during Ex parte Reexamination of the ’351
`
`’348 patent (Van Breemen ’348 Reexam DecI.”
`
`Declaration of Dr. Yeboah submitted during inter partes reexamination of parent
`
`Declaration of Dr. Yeboah submitted during prosecution of parent patent U.S.
`
`DEUTCH, 1995, ”Menstrual pain in Danish women correlated with low n-3
`
`DIEZ et aI., 2003, ”The role of the novel adipocyte-derived hormone adiponectin in
`
`Eichberg, ”Lecithin — It Manufacture and Use in the Fat and Oil Industry,” Oils and
`
`ELLINGSEN et aI., 1987, ”Biochemistry of the autontic processes in Antarctic kriII post
`
`Examiner
`
`magma K my
`
`Date
`
`09/02/2018
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/D.K.W/
`
`

`

`Pficeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`——
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`
`NONPATENT LITERATURE DOCUMENTS
`
`EP Opposition filed May 8, 2015 by Olympic Seafood AS, EP Patent No. 2144618
`
`includes: ENGE, "Declaration" MACKENZIE, "Certificate of Analysis" - Callahan
`Innovation
`
`EUNG-HO LEE, et a|., "Studies on the Processing of Krill Sauce," J. Korean Soc. Food
`Nutr. 13(1) 97-106 (1984)
`
`Evidence in Support of Opposition, Rimfrost AS, Australian Patent Application No.
`
`2013227998, filed September 22, 2016, 22 pages
`
`(14409/AU-7/DIV)
`
`Expert Witness Report of Dr. Theodore Welch submitted in relation to ITC
`
`Investigation No. 337-TA-877 (”Welch”)
`
`Farkas, Composition and Physical State of Phospholipids in Calanoid Copepods from
`
`India and Norway, LIPIDS, Vol. 23, No. 6 (1988)
`
`FELIX-VALENZUELA et a|., 2001, ”Supercritical COZ/Ethanol Extraction of Astaxanthin
`from Blue Crab (Callinectes Sapidus) Shell Waste”, Journal of Food Process
`Engineering, 24: 101-112
`-- Final Prospectus dated May 11, 2001 (”Final Prospectus”)
`Fisheries Agency, General Report on Research and Development of Techniques in
`
`
`
`Processing and Utilization of Marine Products, Chapter 6, Development of
`
`technology for recovery of valuable substances (astaxanthin) from krill, by Takao
`Fujita, pp. 273-307 (March 1985); Japanese language document
`
`FoIch, et a|., A Simple Method for the Isolation and Purification of Total Lipids from
`Animal Tissues. J. Biol. Chem., 226, 497-509 (1957)
`
`FOX and SCH EER, 1941, ”Comparative Studies of the Pigments of Some Pacific Coast
`
`Echinoderms”, The Biological Bulletin, 441-455
`
`FRICKE, et a|., 1-O-Alkylglycerolipids in Antarctic Krill (Euphausia Superba Dana),
`
`Comp. Biochem. Physiol. (1986) 85B(1): 131-134
`
`FRICKE, et a|., Lipid, Sterol and Fatty Acid Composition of Antarctic Krill (Euphausia
`
`superba Dana), Lipids (1984) 19(11): 821-827.
`
`GEUSENS et a|., 1994, ”Long-term effect of omega-3 fatty acid supplementation in
`
`active rheumatoid arthritis. A 12-month, double-blind, controlled study”, Arthritis
`
`Rheum., 37(6): 824-9
`
`GIGLIOTTI et a|., "Extraction and characterisation of lipids from Antarctic krill
`
`(Euphausia superba)", Food Chemistry, 2011, vol. 125, no. 3, pages 1028-1036
`
`GILCHRIST and GREEN, 1960, ”The Pigments of Artemia”, Proceedings of the Royal
`
`Society, Series B Biological Sciences, Vol 152 No. 946, pp 118-136
`
`GOODWIN and SRISUKH, 1949, ”Some Observations on Astaxanthin Distribution in
`
`Marine Crustacea”, Department of Biochemistry, University of Liverpool, pp. 268-270
`
`Examiner
`
`Date
`
`09/02/2018
`[DEBORAH K m/
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WERE LINED THROUGH.
`
`/D.K.W/
`
`

`

`Pficeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`Application Number —
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`
`NONPATENT LITERATURE DOCUMENTS
`
`GORDEEV, K.Y., et al. "Fatty Acid Composition of the Main Phospholipids of the
`
`-- Antarctic Krill, Euphausia superba," Chem. Nat. Cmpds. (1990) 26(2), pp. 143-147
`-- GORDEEV, K.Y., et al. "Fatty Acid Composition of the Main Phospholipids of the
`Antarctic Krill, Euphausia superba," Khim. Prirod. Soed. 2 (1990), pp. 181-187
`-_—
`-_-GLO/SO/77/3: 1-61.
`-- Pharmaceutics 5021-6 (1989)
`-- Konservnaya | Ovoshchesushil’naya Promyshlennost, (4), 37-8
`-- Muscle with Supercritical Fluids” Journal of Food Science, 53(6): 1656-1658
`
`
`
`Grit et al., Hydrolysis of phosphatidylcholine in aqueous liposome dispersions, Int. J.
`
`GULYAEV and BUGROVA, 1976 ”Removing fats from the protein paste ”Okean”.
`
`-
`
`HARDARDOTTIR and KINSELLA, 1988, ”Extraction of Lipid and Cholesterol from Fish
`
`Henderson et al., Lipid Composition of the Pineal Organ from Rainbow Trout
`
`(Oncorhynchus mykiss), Lipids, Vol. 29, No. 5, pp. 311-317 (1994) (”Henderson ”)
`
`Herman and Groves, The Influence of Free Fatty Acid Formation on the pH of
`
`Phospholipid-Stabilized Triglyceride Emulsions, Pharmaceutical Research 10(5):774-
`
`776 (1993)
`
`HVA'ITUM, Erlend, et al., "Effect of soybean oil and fish oil on individual molecular
`
`species of Atlantic sa|mon...", Journal of Chromatography B, 748 (2000) 137-149
`
`.' IGARASHI, Daisuke, etal., "Positional DistributionofDHAand EPAin
`
`Phosphatidylcholine and Phosphatidylethanolamine from Different Tissues of
`
`Squids," J. Oleo Sci. Vol. 50, No. 9 (2001)
`-_-
`-_-2009-03-11
`-_-2010-06-24
`-_-No. PCT/I32014/002130, mailed February 3, 2015
`-_-
`-I—-
`
`PCT/I32016/000208, mailed May 13, 2016,
`
`Itano Refrigerated Food Co., Ltd., Bio & High Technology Announcement and Natural
`
`Astaxanthin & Krill Lecithin, pp. 1-16 (on or before December 28, 1994) (”Itano”)
`
`Examiner
`
`Date
`
`09 (1:220:18
`/DEBORAH K ME]
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WERE LINED THROUGH.
`
`[D .K.W/’
`
`

`

`Pficeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`——
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`
`
`
`NONPATENT LITERATURE DOCUMENTS
`
`ITOH et a|., 2007; ”Increased adiponectin secretion by highly purified
`
`eicosapentaenoic acid in rodent models of obesity and human obese subjects”,
`
`Arteriosclerosis, Thrombosis, and Vascular Biology; 27(9): 1918-1925
`
`JOHNSON and LUCAS, Comparison of Alternative Solvents for Oils Extraction, JAOCS
`60(2):229-242 (1983)
`
`JOHNSON et a|., 1978, ”Simple Method for the Isolation of Astaxanthin from the
`
`Basidiomycetous Yeast Phaffia rhodozyma”, Applied and Environmental
`
`Microbiology, 35(6): 1155-1159
`
`JONG-HO LEE, "A Review: Antioxygenic and Peroxide-decomposing Activities of
`
`Antarctic Krill Lipids," J. Korean Soc. Food Mutr. 13(3) pp. 326-333 (1984)
`
`JP Office Action mailed February 23, 2012, JP Patent Application No. 2010-522444
`
`(and English translation)
`
`KI WOONG CHO, et a|., "Lipid and Fatty Acid Composition of the Antarctic Krill
`
`Euphausia superba," Ocean Research 21(2): 109-116 (1999)
`
`KOLAKOWSKA, 1989, ”Krill lipids after frozen storage of about one year in relation to
`
`storage time before freezing”, Die Nahrung Food, 33(3): 241-244
`
`KOLAKOWSKI and GAJOWIECKI, "Optimization of autoproteolysis to obtain and edible
`product 'precipitate' from Antarctic krill," Seafood Science and Technology, pp. 331-
`336
`
`KRIS-ETHERTON et a|., 2002, ”Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and
`Cardiovascular Disease”, Circulation, 106:2747-2757
`
`KRISTENSEN et a|., 1989, ”Dietary supplementation with n-3 polyunsaturated fatty
`
`acids and human platelet function: a review with particular emphasis on implications
`
`for cardiovascular disease”, J. Intern. Med. Suppl. 731:141-50
`
`KUNESOVA et a|., 2006, ”The influence of n-3 polyunsaturated fatty acids and very
`
`low calorie diet during a short-term weight reducing regimen on weight loss and
`
`serum fatty acid composition in severely obese women”, Physiol Res.; 55(1):63-72
`
`KYUN-KU KIM, et a|., "Effects of Cooking and Drying Methods on the Polar Lipds
`
`Composition of Shrimp," Korean J. Food Sci. Technol. Vol. 21, No. 1, pp. 25-30 (1989)
`
`LAIGHT et a|., 1999, ”F2—isoprostane evidence of oxidant stress in the insulin
`
`resistant, obese Zucker rat: effects of vitamin E”, Eur. J. Pharmacol. 377(1): 89-92
`
`LAMBERTSON and BRAEKKAN, 1971, ”Method of Analysis of Astaxanthin and its
`Occurrence in some Marine Products,” J. Sci. Food. Agr., Vol 22(2): 99-101
`
`LE GRANDOIS et a|., Investigation of Natural Phosphatidylholine Sources: Separation
`and Identification by Liquid Chromatography -E|ectrospray Ionization-Tandem Mass
`
`Spectrometry (LC-ESI-MS2) of Molecular Species, J. Agric. Food Chem., 57, 6014-20
`
`(2009) (”Le Grandois”)
`
`Examiner
`Signature
`
`Date
`Considered
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/D.K.W/
`
`

`

`Pficeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`——
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets as necessary) ——
`——
`
`NONPATENT LITERATURE DOCUMENTS
`
`LIBBY et a|., 2006, ”Inflammation and Atherothrombosis: From Population Biology
`
`and Bench Research to Clinical Practice”, J. Amer. CoII. Card., 48 (9, Suppl. A): A33-
`A46
`
`LIN et a|., Effect of Dietary N-3 Fatty Acids Upon the PhosphoIipidMoIecuIar Species
`of the Monkey Retina, Invest Ophthalmol Vis Sci. 1994;35:794-803
`
`LOPEZ et a|., 2004, ”Selective extraction of astaxanthin from crustaceans by use of
`
`supercritical carbon dioxide”, Talanta, 64: 726-731
`
`MANDEVILLE, 1991, ”Isolation and Identification of Carotenoid Pigments, Lipids and
`
`Flavor Active Components from Raw Commercial Shrimp Waste”, Food
`
`Biotechnology, 5(2): 185-195
`
`MEDINA et a|., C Nuclear Magnetic Resonance Monitoring of Free Fatty Acid Release
`
`After Fish Thermal Processing, J. Amer. Oil Chem. Soc. 71(5):479-82 (1994)
`
`MEYERS and BLIGH, 1981, ”Characterization of Astaxanthin Pigments from Heat-
`
`Processed Crawfish Waste”, J. Agric. Food Chem., 29: 505-508
`
`MEYERS, 1977, ”Using Crustacean Meals and Carotenoid-Fortified Diets”, Feedstuffs,
`
`Vol. 49(19)
`
`MEYERS, 1994, ”Developments in world aquaculture, feed formulations, and role of
`carotenoids”, Pure & Appl. Chem, Vol. 66(5): 1069-1076
`
`MILLS et a|., 1989, ”Dietary N-6 and N-3 fatty acids and salt-induced hypertension in
`
`the borderline hypertensive rat”, Lipids, 24(1): 17-24
`
`MOATES and VAN BENTEM, 1990, ”Separating out the value”, Food Science and
`
`Technology Today, 4(4): 213-214
`
`Neptune kriII Oil's Unique Properties", INTERNET CITATION, 2011,
`
`URL:http://www.nowfoods.com/Products/ProductFAQs/081008/htm
`
`Neptune Technologies & Bioressources Soon to Obtain a Major Patent in Over 30
`
`Countries” (”2001 Press Release,”)
`
`NIKOLAEVA, 1967 ”Amino acid composition of protein-coagulate in krill”, VNIRO,
`63:161-4
`
`Notice of Acceptance of Application, Australian Patent Application No. 2013227998,
`
`mailed October 5, 2016, 2 pages
`
`
`
`(14409/AU-7/DIV)
`-- October 24, 2012 Office Action, ’675 patent
`-- Office Action dated January 5, 2012, ’351 patent
`PHLEGER, et al. (2002) ”Interannual and between species comparison in the lipids,
`fatty acids, and steroIs of Antarctic kriII from the US AMLR Elephant Island survey
`area: 1997 and 1998”. Comp Biochem Physiol 131B:733—747
`
`-
`-
`
`Examiner
`
`Date
`
`[mam K WARE;
`
`meg/20m
`
`Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through
`EXAMINER:
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/D.K.Wf
`
`

`

`Pficeipt date: 06/29/2018
`
`16/023,146 .. GAE}: 1651
`
`INFORMATION DISCLOSURE
`
`Complete if Known
`
`——
`
`STATEMENT BY APPLICANT
`
`(Use as many sheets